Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Microfluidic Device Could Improve Biomarker Analyses

By Labmedica International staff writers
Posted on 08 Jul 2014
Print article
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).
A new microfluidic device could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria.

The physical attributes of cells are important biomarkers in medicine, whether extracting circulating tumor cells from the blood of a cancer patient, or to measure the elasticity of red blood cells due to malaria infection.

Scientists at The Royal Institute of Technology (KTH; Stockholm, Sweden) proposed a microfluidic device that can sort elastic capsules by their deformability. The device consists of a duct embedded with a semi-cylindrical obstacle, and a diffuser which further enhances the sorting capability. The KTH team used extensive computational simulations to model a microfluidic device that would sort cells according to their elasticity. The work draws on numerical techniques and computational capabilities developed in the last decade to handle the complexity of microscale flows.

Most cell sorting techniques rely on the difference between chemical properties of the cells. The problem is chemical properties do not give pathologists the full picture. Two cells can have very similar chemical properties, but different physical properties. Size, shape and elasticity, or deformability, are important attributes that can be also enable cell sorting, given the right kind of device.

The scientists demonstrated that the device can operate reasonably well under changes in the initial position of the capsule. The efficiency of the device remains essentially unaltered under small changes of the obstacle shape from semicircular to semi-elliptic cross-section. Confinement along the direction perpendicular to the plane of the device increases its efficiency. This work is the first numerical study of cell sorting by a realistic microfluidic device.

Dhrubaditya Mitra, PhD, an assistant professor in theoretical physics and a coauthor of the study offers an example of why elasticity matters. “If you are infected with malaria, the physical nature of your red blood cells changes. They become harder and red blood cells also become harder as they get older too. These harder red blood cells are filtered by the spleen which acts like a sieve. The softer red blood cells can squeeze through the gaps but the harder ones cannot.” The study was published on June 20, 2014, in the journal Soft Matter.

Related Links:

The Royal Institute of Technology



Print article

Channels

Clinical Chemistry

view channel

New Approach Improves Identification of Women at High Risk of Preeclampsia

A new meta-analysis examining 92 cohort studies involving over 25 million pregnancies has provided an unprecedented understanding of risk factors for preeclampsia—some risk factors being strong enough to warrant that a pregnant woman starts on prophylactic treatment with acetylsalicylic acid (ASA) when she has only one.... Read more

Genetic Tests

view channel

Patterns of MicroRNA Expression Distinguish Patients with Asthma and Allergic Rhinitis

Subsets of circulating micro RNAs (miRNAs) are uniquely expressed in asthmatic patients and in patients with allergic rhinitis (AR) and have potential for use as noninvasive biomarkers to diagnose and characterize these diseases. MicroRNAs are a class of about 20 nucleotides-long RNA fragments that block gene expression... Read more

Pathology

view channel

Liver Cancer May Be Diagnosed from Altered Sugar Metabolism

Altered gene expression that causes cancerous cells to metabolize fructose differently from healthy cells could be a significant new biomarker for diagnosing liver cancer. Dietary fructose is primarily metabolized in the liver and it has now been demonstrated that, compared with normal hepatocytes, hepatocellular carcinoma... Read more

Industry News

view channel

R-Biopharm and Merck Partner on Companion Diagnostics

R-Biopharm AG (Darmstadt, Germany) and Merck KGaA (Darmstadt, Germany) have entered into an agreement that constitutes their first collaboration, which will initially focus on developing and launching companion diagnostics. Companion diagnostics play a central role in personalized medicine by helping to find specific... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.